Health hot news

Aerocrine AB (STO:AEROB) announced that its handheld airway inflammation monitor, NIOX MINO®, has been registered for marketing and sale in China. Aerocrine’s method of measuring airway inflammation, using exhaled nitric oxide (NO) tests, has also been incorporated into China’s national guidelines for asthma management. Tests for airway inflammation have received a reimbursement code.

A bipartisan group of five senators has written a letter asking Senate leaders to oppose a House-approved bill (HR 6331) to delay implementation of the Medicare competitive bidding program for durable medical equipment, CQ HealthBeat reports. The letter — addressed to Senate Majority Leader Harry Reid (D-Nev.

OBS Medical’s predictive patient safety technology, Visensia®, was the focus of a large study and peer-reviewed paper that was published in the June 23rd issue of Archives of Internal Medicine, published by the American Medical Association. The University of Pittsburgh Medical Center (UPMC) conducted this independent evaluation and published “Defining the Incidence of Cardiorespiratory Instability in Patients in Step-down Units Using an Electronic Integrated Monitoring System.

Medical Machines Online is happy to announce the current overstock and release of a new ECG Machine, the GE Marquette MAC 1200 Interpretive Deluxe. The GE Marquette MAC 1200 Resting ECG Analysis System is a comprehensive and practical solution for clinicians at smaller hospitals, clinics and physician offices. New ECG Machine This overstocked ECG

eCardio Diagnostics launches an extended monitoring device, the eTriggerPLUS, in conjunction with an extended monitoring service (EMS). Extended monitoring devices provide real-time data analysis allowing physicians to capture daily ECG information through pre-defined and programmable intervals. The eTriggerPLUS is the first generation of extended monitoring devices offered by eCardio.

A new technique that effectively delivers drugs to the eyes, using microscopic needles, could offer hope to the millions of patients worldwide suffering from common eye diseases that threaten vision such as glaucoma, macular degeneration and diabetic retinopathy.

Researchers at the Institute for Ultrafast Spectroscopy and Lasers (IUSL) at The City College of New York (CCNY) have conducted time-resolved fluorescence measurement and optical imaging studies that demonstrate the efficacy of Cytate as a fluorescence marker to detect prostate cancer. Cytate, a contrast agent that conjugates to receptors on prostate cancer cells, exhibited greater fluorescence when applied to cancerous prostate tissue as opposed to normal prostate tissue.

Molecular Profiles, a global leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors worldwide, announces a new poster to demonstrate the ability of nanoPASS (nanoscale Predictive Analytical Screening Solution) to characterise the surface energy of an API material. nanoPASS, an innovative new service platform, was launched earlier this year as a new addition to Molecular Profiles’ nanoscale analytical services offering.

Rigaku Americas Corporation today announced the introduction of a new, compact, fully integrated high-resolution X-ray diffraction system, the Rigaku RAPID II. The latest member of the RAPID family of large area curved imaging plate (IP) detectors, the RAPID II combines every component needed for a high-performance X-ray diffraction system delivering no-compromise performance for applications ranging from applied crystallography to chemical crystallography.

ACUVUE® OASYS™ Brand Contact Lenses for ASTIGMATISM, became the fourth contact lens in the ACUVUE® family of products to receive the AOA Seal of Acceptance for Ultraviolet Absorbing Contact Lenses from the American Optometric Association’s Commission on Ophthalmic Standards. The announcement was made in Seattle at Optometry’s Meeting™, the annual meeting of the American Optometric Association (AOA).